Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

Diabetes mellitus is a chronic disease with a higher risk of associated infections. HIV
infection severely affects diabetic patients and acts as a significant health concern. Highly …

Background: Since the introduction of Antiretroviral Therapy (ART), the life expectancy and
health quality for patients infected with Human Immunodeficiency Virus (HIV) have …

The treatment of AIDS with combination antiretroviral therapy (cART) remains lifelong largely
because the virus persists in latent reservoirs. Elimination of latently infected cells could …

Background Despite control of HIV infection under antiretroviral therapy (ART), immune T-
cell activation persists in patients with controlled HIV infection, who are at higher risk of …

Treatment of HIV infection is a lifelong process and associated with chronic diseases. We
evaluated the prevalence and predictors of metabolic syndrome (MetS) and cardiovascular …

Antiretroviral therapy (ART), which is a life-long therapeutic option, remains the only
currently effective clinical method to treat HIV-1 infection. However, ART may be toxic to vital …

Many seminal advances have been made in human immunodeficiency virus (HIV)/AIDS
research over the past four decades. Treatment strategies, such as gene therapy and …

Abstract Background The 2023 Multisociety Guideline for the Management of Chronic
Coronary Disease (CCD) updates recommendations for CCD, formerly known as “stable …

It is now well understood that HIV-positive individuals, even those under effective ART, tend
to develop a spectrum of cognitive, motor, and/or mood conditions which are contemporarily …